Deadline for manuscript submissions: 15 December 2021Print Special Issue Flyer (7)
Professor, Dept. of Emergency Medicine,Univ. of Health Sciences, Istanbul Education and Research Hospital, Fatih, Istanbul, Turkey
Interests: Cardiopulmonary resuscitation, Emergency management, Pain management, Trauma, Intensive Care Medicine
There are currently no recommended specific treatments for the group with severe COVID-19, therefore, supportive treatment is essential. For example, many antivirals and antibiotics were launched as promising remedies against the disease, while little benefit has been proved so far. Likewise, “cytokine storm” has been targeted as a major determinant of severity of the clinical course and mortality, but few data have been published so far on interventions with significant benefit on the patients’ side. Respiratory failure is the most important killer of the patients with critical condition. High-flow nasal oxygenation and non-invasive ventilation can be sufficient for mild-to moderate cases. Expedient recognition and decisions for aggressive measures such as permanent control of airway and positive-pressure ventilation, along with administration of corticosteroids and some other agents, should be evaluated in more severe cases. Prone position is mostly associated with a better course than supine position in resuscitation of patients with critical condition. Extracorporeal membrane oxygenation (ECMO) is one of the last-chance measures to restore vital functions for the patient in extremis who do not respond to conventional interventions.
Sepsis and shock are also catastrophic events that should be recognized and managed expediently for favorable outcomes. If the mean arterial pressure (MAP) cannot be kept above 65 mmHg with intravenous (IV) hydration and lactate cannot be maintained below 2 mmol/L, vasopressor support should definitely be started. Development of coagulopathy is associated with high mortality in patients with COVID-19. Therefore, low molecular weight heparin (LMWH) should be used for prophylactic purposes.
Finally, there are numerous agents still debated in the medical community without robust evidence to support their use.
The objective of this special issue is to help healthcare providers conceptualize the current advances in implementation, indications, drawbacks, practical tips of the management strategies of COVID-19 and its complications for the practitioner in emergency and critical care. Clinical research and review / state-of-the-art articles, case reports or case series on the use of the agents and interventions in COVID-19 care are welcomed.
COVID-19, Resuscitation, Treatment, Critical care, CPR, Emergency care, Shock, Extracorporeal membrane oxygenation, Prone position, Positive-pressure ventilation, Non-invasive ventilation
Manuscripts should be submitted online by submit system. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Original articles, case reports or comprehensive reviews are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website. Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a double-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Signa Viate is an international peer-reviewed open access journal published by MRE Press. As of January 2021, Signa Vitae will change to a bimonthly journal. Please visit the Instructions for Authors page before submitting a manuscript.The Article Processing Charge (APC) for publication in this open access journal is $1200. We normally offer a discount greater than 30% to all contributors invited by the Editor-in-Chief, Guest Editor (GE) and Editorial board member. Submitted papers should be well formatted and use good English.
Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,200 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.
Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.
Chemical Abstracts Service Source Index The CAS Source Index (CASSI) Search Tool is an online resource that can quickly identify or confirm journal titles and abbreviations for publications indexed by CAS since 1907, including serial and non-serial scientific and technical publications.
IndexCopernicus The Index Copernicus International (ICI) Journals database’s is an international indexation database of scientific journals. It covered international scientific journals which divided into general information, contents of individual issues, detailed bibliography (references) sections for every publication, as well as full texts of publications in the form of attached files (optional). For now, there are more than 58,000 scientific journals registered at ICI.
Geneva Foundation for Medical Education and Research The Geneva Foundation for Medical Education and Research (GFMER) is a non-profit organization established in 2002 and it works in close collaboration with the World Health Organization (WHO). The overall objectives of the Foundation are to promote and develop health education and research programs.
Scopus: CiteScore 0.5(2019) Scopus is Elsevier's abstract and citation database launched in 2004. Scopus covers nearly 36,377 titles (22,794 active titles and 13,583 Inactive titles) from approximately 11,678 publishers, of which 34,346 are peer-reviewed journals in top-level subject fields: life sciences, social sciences, physical sciences and health sciences.
Embase Embase (often styled EMBASE for Excerpta Medica dataBASE), produced by Elsevier, is a biomedical and pharmacological database of published literature designed to support information managers and pharmacovigilance in complying with the regulatory requirements of a licensed drug.